Litcius/Paper detail

Structure guided generation of thieno[3,2-<i>d</i>]pyrimidin-4-amine <i>Mycobacterium tuberculosis bd</i> oxidase inhibitors

Sarah M. Hopfner, Bei Shi Lee, Nitin Pal Kalia, Marvin J. Miller, Kévin Pethe, Garrett C. Moraski

2021RSC Medicinal Chemistry26 citationsDOIOpen Access PDF

Abstract

Screening for inhibitors of Cyt-<italic>bd</italic> in <italic>Mycobacterium bovis</italic> BCG and <italic>Mycobacterium tuberculosis</italic> revealed thieno[3,2-<italic>d</italic>]pyrimidine (<bold>7</bold>) which through SAR efforts resulted in an improved analogue (<bold>19</bold>) of this scaffold.

Topics & Concepts

Mycobacterium tuberculosisMycobacterium bovisContext (archaeology)ChemistryTuberculosisIC50MycobacteriumMicrobiologyBiochemistryBiologyIn vitroMedicinePaleontologyPathologyTuberculosis Research and EpidemiologyMycobacterium research and diagnosisCancer therapeutics and mechanisms
Structure guided generation of thieno[3,2-<i>d</i>]pyrimidin-4-amine <i>Mycobacterium tuberculosis bd</i> oxidase inhibitors | Litcius